GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (LTS:0HB0) » Definitions » Inventories, Raw Materials & Components

Agios Pharmaceuticals (LTS:0HB0) Inventories, Raw Materials & Components : $0.09 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Agios Pharmaceuticals Inventories, Raw Materials & Components?

Agios Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $0.09 Mil.

Agios Pharmaceuticals's quarterly raw materials stayed the same from Jun. 2024 ($0.09 Mil) to Sep. 2024 ($0.09 Mil) but then declined from Sep. 2024 ($0.09 Mil) to Dec. 2024 ($0.09 Mil).

Agios Pharmaceuticals's annual raw materials increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.05 Mil) and increased from Dec. 2023 ($0.05 Mil) to Dec. 2024 ($0.09 Mil).


Agios Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Agios Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agios Pharmaceuticals Inventories, Raw Materials & Components Chart

Agios Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.05 0.09

Agios Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.09 0.09 0.09 0.09

Agios Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Agios Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Agios Pharmaceuticals Headlines

No Headlines